Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

The main breakthrough in tumor immunotherapy was the discovery of immune checkpoint (IC) proteins, which act as a potent suppressor of the immune system by a myriad of mechanisms. After that, scientists focused on the immune checkpoint molecules mainly. Thereby, much effort was spent to progress nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Naimi, Adel, Mohammed, Rebar N., Raji, Ahmed, Chupradit, Supat, Yumashev, Alexei Valerievich, Suksatan, Wanich, Shalaby, Mohammed Nader, Thangavelu, Lakshmi, Kamrava, Siavash, Shomali, Navid, Sohrabi, Armin D., Adili, Ali, Noroozi-Aghideh, Ali, Razeghian, Ehsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991803/
https://www.ncbi.nlm.nih.gov/pubmed/35392976
http://dx.doi.org/10.1186/s12964-022-00854-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991803/
https://www.ncbi.nlm.nih.gov/pubmed/35392976
http://dx.doi.org/10.1186/s12964-022-00854-y

Ejemplares similares